MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$11,874,000
+31.4%
341,294
+35.6%
1.52%
+51.8%
Q1 2022$9,035,000251,6591.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
Bridge City Capital, LLC 22,659$1,042,0870.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders